Federal Injunction Blocks Ranbaxy from Marketing in U.S.

WASHINGTON –The Justice Department filed a consent decree today preventing generic drug giant Ranbaxy from selling drugs made at four of its manufacturing plants until it brings them into compliance with the FDA’s quality standards.